Patents
Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
08/2010
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/03/2010US7767660 Macrocyclic indole compounds, e.g., (7R)-14-cyclohexyl-21,24-dimethyl-7,8-dihydro-6H-7,11-(epiminoethanoiminopropanothio iminomethano)indolo[1,2-e][1,5]benzoxazocin-15-one 17,17-dioxide; hepatitis C virus polymerase inhibitors
07/2010
07/29/2010US20100190766 Antibacterial agents
07/22/2010WO2010082627A1 Process for producing 2-hydroxymethylmorpholine salt
07/20/2010CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
07/13/2010CA2567776C Vasopressin v1a antagonists
07/08/2010US20100173890 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
07/08/2010US20100173823 Alpha2c adrenoreceptor agonists
07/01/2010US20100168080 Novel compounds useful as cc chemokine receptor ligands
06/2010
06/24/2010US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
06/24/2010US20100160291 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
06/24/2010US20100160280 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
06/17/2010US20100152440 NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR (RyR2)
06/16/2010EP2196469A1 Conjugates with anti-inflammatory activity
06/16/2010CN1989141B Bicyclic heterocycles as HIV integrase inhibitors
06/10/2010WO2010065717A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010CA2745121A1 Morpholinone compounds as factor ixa inhibitors
06/08/2010US7732434 9-Amino-14,30-dichloro-5-methyl-4,24-dioxa-3,8,10,16,19-pentaazatetracyclo-[23.2.2.212,15.02,6 ]hentriaconta-1(27),2,5,8,12,14,21,25,28,30-decaene-7,17-dione; inhibit the processing of amyloid precursor protein; Alzheimer's Disease (AD) and Down's Syndrome
06/03/2010WO2010062565A1 Muscarinic agonists
05/2010
05/27/2010US20100129473 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
05/20/2010WO2010001407A8 Synthesis of 11-(4-[2-(2-hydroxyethoxy)ethyl]- piperazinyl)dibenzo[b,f][1,4]thiazepine and its fumarate salt
05/18/2010US7718646 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
05/18/2010US7718645 4-[4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cycloalkylalkyl nitriles, carboxy acids or esters, amides, e.g., a -cyclohexylacetonitrile; diglyceride acyltransferase inhibitors for treating type II diabetes and obesity
05/13/2010US20100120742 Rexinoid compound having alkoxy group
05/13/2010US20100120716 Macrocyclic hepatitis c serine protease inhibitors and uses therefor
05/12/2010CN1794997B 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
05/11/2010US7713966 Heterobicyclic metalloprotease inhibitors
05/06/2010US20100113770 O-substituted hydroxyaryl derivatives
05/06/2010US20100113414 Thiazolyl-dihydro-indazoles
05/05/2010CN101060847B Loxapine analogs and methods of use thereof
05/04/2010US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
04/2010
04/29/2010US20100105657 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
04/28/2010EP1363640B1 Nucleic acid derivatives
04/28/2010CN1658855B O-substituted hydroxyaryl derivatives
04/22/2010US20100099865 Heat shock protein 90 inhibitors
04/08/2010US20100087418 Benzoxazepine derivatives and use thereof
04/01/2010US20100081700 Hepatitis C Virus Inhibitors
03/2010
03/25/2010WO2010001407A3 Synthesis of ll-(4-[2-(2-hydroxyethoxy)ethyl]- piperazinyl)dibenzo[b,f][1,4]thiazepine and its fumarate salt
03/25/2010US20100076046 Antiviral Indoles
03/18/2010US20100069358 Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/16/2010US7678784 4-amino-23,26-dichloro-13-oxa-3,5,18,21-tetraazatricyclo[20.2.2.29,12]octacosa-1(24),4,9,11,15,22,25,27-octaene-6,8,20-trione 8-(O-ethyloxime); beta -amyloid production blocking agent; neurodegenerative diseases, cognition activator; Alzheimer's disease, Down syndrome
03/11/2010US20100063027 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity
03/09/2010US7674921 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts
02/2010
02/25/2010WO2010021149A1 Spiro compound capable of inhibiting acid secretion
02/18/2010WO2010018268A1 Novel (rs)-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-il)-7h or 9h-purines having antitumour activity
02/18/2010US20100041637 1,3-Oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11ß-hydroxysteroid dehydrogenase 1
02/18/2010US20100041619 Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders
02/16/2010CA2478183C Substituted amides
02/09/2010US7659263 (E)-3-[4-({1-[(11-cyclohexyl-8-methoxy-4,5-dihydro-6-oxa-1-thia-3b-azabenzo[e]cyclopenta[a]azulene-2-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]acrylic acid; RNA-dependent RNA polymerase inhibitory activity; hepatitis C
01/2010
01/26/2010US7652003 Macrocyclic β-secretase inhibitors
01/21/2010US20100016285 Heterocyclidene-n-(aryl) acetamide derivative
01/21/2010US20100016284 Compounds and uses thereof - 151
01/21/2010US20100016283 Compounds and uses thereof - 150
01/21/2010US20100016272 Heteroarylacrylamides and their use as pharmaceuticals
01/21/2010US20100016164 Haloalkylsulfonanilide derivatives or salt thereof, herbicide comprising the derivatives as active ingredient, and use of the herbicide
01/19/2010US7649001 Fused benzene derivative and use
01/07/2010US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/2009
12/31/2009US20090325950 Benzoxazine derivatives and uses thereof
12/30/2009EP2137157A1 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same
12/30/2009EP1805202B1 Conjugates with anti-inflammatory activity
12/24/2009US20090317328 Tricyclic oxazepines as in vivo imaging compounds
12/22/2009CA2475383C Method for extracting a macrolide from biomatter
12/10/2009WO2009146772A1 New terpenes and macrocycles
12/10/2009CA2726883A1 New terpenes and macrocycles
12/02/2009EP2125750A2 Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/01/2009US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma
11/2009
11/25/2009EP2123644A1 Benzoxazepine derivatives and use thereof
11/24/2009US7622461 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
11/18/2009EP2118079A1 Synthetic macrocyclic compounds for treating cancer
11/12/2009WO2009071631A3 Dibenzoazepine and dibenzooxazepine trpa1 agonists
11/10/2009US7615549 Substituted pyrrolidinones, their manufacture and their use as medicaments
11/03/2009CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
10/2009
10/22/2009US20090264404 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
10/21/2009CN101563347A Vasopressin V1a antagonists
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258884 Substituted amides
10/14/2009CN101558056A Process for production of anthranilamide compound
10/13/2009US7601695 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal
10/06/2009US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
09/2009
09/24/2009US20090239839 Receptor antagonist
09/23/2009CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors
09/22/2009US7592333 Loxapine analogs and methods of use thereof
09/22/2009US7592331 2-(1-Amino-isoquinolin-6-ylamino)-4,11-diazatricyclo[14.2.2.1(6,10)]henicosa-1(19),6,8,10(21),16(20),17-hexaene-3,12-dione trifluoroacetic acid salt; serine protease inhibitors; arterial cardiovascular thromboembolic disorders; cerebral, kidney, pulmonary embolisms; acute coronary syndrome;prosthetics
09/22/2009CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
09/08/2009US7585889 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure
09/03/2009WO2009107389A1 Tricyclic compound
09/03/2009US20090221689 Macrocyclic Modulators of the Ghrelin Receptor
09/03/2009US20090221551 Substituted fused[1,2] imidazo[4,5c] ring compounds and methods
09/01/2009US7582752 Process for the resolution of nefopam
09/01/2009US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
09/01/2009CA2417353C Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-one, and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
08/2009
08/27/2009US20090215742 Amide resorcinol compounds
08/25/2009US7579463 Crown ether derivatives
08/20/2009US20090209593 Novel antibacterial agents
08/18/2009US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 21